Vimarsana
Biggest News Aggregation in the World

Page 2 - Pharma Canada News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Canada. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Canada Today - Breaking & Trending Today

Sun Pharma Canada: Health Canada Approves ABSORICA LD - Quick Facts - Vimarsana News

Sun Pharma Canada: Health Canada Approves ABSORICA LD - Quick Facts

(RTTNews) - Sun Pharma Canada announced Health Canada's approval of PRABSORICA LD. It is indicated for the treatment of severe nodular and/or infl...

DRUG FAIL: The Liberal government's 'safer supply' is fuelling a new opioid crisis - Vimarsana News

DRUG FAIL: The Liberal government's 'safer supply' is fuelling a new opioid crisis

In this special report, Adam Zivo details how drugs handed out for free are being sold on the black market to fund fentanyl addictions.

Drug fail: The Liberal government's 'safer supply' is fuelling a new opioid crisis - Vimarsana News

Drug fail: The Liberal government's 'safer supply' is fuelling a new opioid crisis

In this special report, Adam Zivo details how drugs handed out for free are being sold on the black market to fund fentanyl addictions.

Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Nonmetastatic Prostate Cancer - Vimarsana News

Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Nonmetastatic Prostate Cancer

Pfizer and Astellas announce positive top-line results from Phase 3 EMBARK trial MARKHAM, ON, March 23, 2023 /CNW/ - Astellas Pharma Inc. , the parent company of Astellas Pharma Canada, Inc., has... | March 23, 2023

Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy - Vimarsana News

Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy

/CNW Telbec/ - Lupin Pharma Canada, a wholly-owned subsidiary of Lupin Limited (Lupin), announced today the launch of Intrarosa® (prasterone vaginal ovules)...